Lilly, IU Deepen Work on Clinical Trial Innovation Ecosystem
Eli Lilly and Company has entered a five-year collaboration with Indiana University that will provide up to $40 million to expand clinical trial access...
IQVIA Names AWS as Preferred Agentic Cloud Provider
IQVIA, which is a leading global provider when it comes to clinical research services, commercial insights, and healthcare intelligence to the life sciences and...
CDMO-CRDO Partner For Requirements of the Biologics Market
A leading global contract development and manufacturing organization - CDMO for biopharmaceuticals, Rentschler Biopharma, and Coriolis Pharma, which is a globally operating contract research and development...
US-UK Zero Tariff Deal Reshapes Pharmaceutical Trade Landscape
Key takeaways:
The UK secured exclusive zero percent tariff access for pharmaceuticals entering the US, removing a major source of trade uncertainty.
The revised...
PLI Incentives Aim to Accelerate API Manufacturing in India
India's Department of Pharmaceuticals has launched a fresh application round under the Production Linked Incentive (PLI) Scheme targeting two high-priority active pharmaceutical ingredients, Meropenem,...
AI-Assisted Fetal Screening Sets New Standard at Mount Sinai
Mount Sinai obstetricians have become the first in New York City to use FDA-cleared artificial intelligence technology designed to enhance prenatal ultrasound evaluations for...
Advanced Clinical Trial Support Hub Launched in South Korea
Leading healthcare solutions company in Asia, Zuellig Pharma, on November 30, 2025, confirmed through an announcement the grand opening of its new state-of-the-art Clinical...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...